Pitango HealthTech Overview
Pitango HealthTech is a dedicated HealthTech fund investing in early stage companies in digital health, medical devices, life sciences and therapeutics. Pitango has been a leader in healthcare investment in Israel for nearly three decades, investing in over 50 healthcare companies with 15 successful exits to date. The fund is part of the Pitango VC platform with over $3 billion under management, investments in more than 300 companies and has overseen 91 exits and IPOs - Israel's largest and longest standing venture capital fund.
Latest News
growth-positive
From red tape to revenue: The growth of business-to-government partnerships | CTech
The article discusses the growing trend of business-to-government (B2G) partnerships, highlighting how companies of all sizes are increasingly engaging with government entities to achieve scale, longevity, and global expansion. Chemi Peres, Managing Partner at Pitango, emphasizes the benefits of B2G collaborations, such as long-term contracts and stability, which are becoming more accessible due to digital transformation and the integration of innovative technologies. The article also explores how private sector innovation is influencing diplomacy and international relations, with examples of countries investing in tech infrastructure and dual-use technologies. The piece suggests that Israel should enhance its investment in dual-use capabilities and support Israeli companies in penetrating foreign B2G markets.
growth-positive
"If we turn our people into enthusiastic embedders of technology, if we share the benefits of dual use, if we end political disruptions, and if we move towards a more peaceful era, then we can meet every challenge posed by evolving global calibrations," writes Chemi Peres, Managing Partner and Co-Founder at Pitango.
The article, written by Chemi Peres, Managing Partner and Co-Founder at Pitango, discusses the evolving global investment landscape and the emergence of giraffes—hyperscale companies that are significantly larger than unicorns. It highlights the shift in investment strategies, focusing on long-term stability and value creation rather than quick exits or high valuations without substance. The article emphasizes the potential for Israel to become a leading economy by fostering an innovation-driven ecosystem. It underscores the importance of adapting to new technologies and recalibrating investment expectations to meet the challenges of a rapidly changing world.
growth-positive
Pitango leases offices in Tel Aviv's Landmark tower
Pitango, a veteran Israeli venture capital fund, has leased 1,400 square meters of office space in Melisron and AFI Properties Landmark A high-rise office tower in Tel Aviv for NIS 40 million annually over 10 years. This move is indicative of the shift in Israels venture capital sector from Herzliya to the Sarona district of Tel Aviv. Pitango, founded in 1993, has invested $3 billion since its establishment and has $465 million available for investment. Despite facing increased competition from younger and foreign funds, Pitango continues to make prominent investments.
InvestmentExpand
growth-positive
Pitango HealthTech announces first closing of new $175 million fund | CTech
Pitango HealthTech, a dedicated healthcare fund of Pitango VC, has announced the first closing of its second healthcare fund, Pitango HealthTech II. The fund, which is worth $175 million, will invest in healthcare innovation, including personalized medicine, medical devices and diagnostics, AI, software, and data infrastructure. The fund has already made several investments, including in QuantHealth.ai, an AI company focused on clinical trial simulations, and Nevia Bio, a FemTech company developing an AI-based biomarker platform for early detection of women’s health diseases.
Investment
growth-positive
Pitango HealthTech adds Hila Karah as Managing Partner and Joel Schoppig as Senior Principal | CTech
Pitango HealthTech has announced the appointment of Hila Karah as Managing Partner and Joel Schoppig as Senior Principal. They will join the existing team of Managing Partner Ittai Harel and Venture Partner Jonathan Glazer. Karah brings over 20 years of experience in life sciences investment in the U.S and Israel, while Schoppig joins Pitango after serving as VP Strategy at Healthy.io. Pitango HealthTechs portfolio includes companies such as Protai, Visby Medical, TScan, Connie Health, DouxMatok, Plantish, Clew Medical, and HomeThrive.
Management Changes
Team Members
6
Web & Social Links
| Website | www.pitango.com/us/pitango-healthtech/ |
Locations
Leonardo da Vinci St 2, Tel Aviv-Yafo, 6473926, Israel
Photos & Videos
No files yet
Pitango HealthTech Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—Tags (21)
diagnosticsartificial-intelligencemedical-device-manufacturersdigital-healthcarehealthcare-itaging-populationpharmaceuticalslife-sciencesfoodtechbioconvergencehealthcaremedical-technologieshealthcare-providersdata-sciencebiotechnologyhealth-managementmedical-devicesbioinformaticsagtechgeneticsdrug-developmentPitango HealthTech Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
Pitango HealthTech Lifecycle
Pitango HealthTech News
8 articles
growth-positive
From red tape to revenue: The growth of business-to-government partnerships | CTech
The article discusses the growing trend of business-to-government (B2G) partnerships, highlighting how companies of all sizes are increasingly engaging with government entities to achieve scale, longevity, and global expansion. Chemi Peres, Managing Partner at Pitango, emphasizes the benefits of B2G collaborations, such as long-term contracts and stability, which are becoming more accessible due to digital transformation and the integration of innovative technologies. The article also explores how private sector innovation is influencing diplomacy and international relations, with examples of countries investing in tech infrastructure and dual-use technologies. The piece suggests that Israel should enhance its investment in dual-use capabilities and support Israeli companies in penetrating foreign B2G markets.
growth-positive
"If we turn our people into enthusiastic embedders of technology, if we share the benefits of dual use, if we end political disruptions, and if we move towards a more peaceful era, then we can meet every challenge posed by evolving global calibrations," writes Chemi Peres, Managing Partner and Co-Founder at Pitango.
The article, written by Chemi Peres, Managing Partner and Co-Founder at Pitango, discusses the evolving global investment landscape and the emergence of giraffes—hyperscale companies that are significantly larger than unicorns. It highlights the shift in investment strategies, focusing on long-term stability and value creation rather than quick exits or high valuations without substance. The article emphasizes the potential for Israel to become a leading economy by fostering an innovation-driven ecosystem. It underscores the importance of adapting to new technologies and recalibrating investment expectations to meet the challenges of a rapidly changing world.
growth-positive
Pitango leases offices in Tel Aviv's Landmark tower
Pitango, a veteran Israeli venture capital fund, has leased 1,400 square meters of office space in Melisron and AFI Properties Landmark A high-rise office tower in Tel Aviv for NIS 40 million annually over 10 years. This move is indicative of the shift in Israels venture capital sector from Herzliya to the Sarona district of Tel Aviv. Pitango, founded in 1993, has invested $3 billion since its establishment and has $465 million available for investment. Despite facing increased competition from younger and foreign funds, Pitango continues to make prominent investments.
InvestmentExpand
growth-positive
Pitango HealthTech announces first closing of new $175 million fund | CTech
Pitango HealthTech, a dedicated healthcare fund of Pitango VC, has announced the first closing of its second healthcare fund, Pitango HealthTech II. The fund, which is worth $175 million, will invest in healthcare innovation, including personalized medicine, medical devices and diagnostics, AI, software, and data infrastructure. The fund has already made several investments, including in QuantHealth.ai, an AI company focused on clinical trial simulations, and Nevia Bio, a FemTech company developing an AI-based biomarker platform for early detection of women’s health diseases.
Investment
growth-positive
Pitango HealthTech adds Hila Karah as Managing Partner and Joel Schoppig as Senior Principal | CTech
Pitango HealthTech has announced the appointment of Hila Karah as Managing Partner and Joel Schoppig as Senior Principal. They will join the existing team of Managing Partner Ittai Harel and Venture Partner Jonathan Glazer. Karah brings over 20 years of experience in life sciences investment in the U.S and Israel, while Schoppig joins Pitango after serving as VP Strategy at Healthy.io. Pitango HealthTechs portfolio includes companies such as Protai, Visby Medical, TScan, Connie Health, DouxMatok, Plantish, Clew Medical, and HomeThrive.
Management Changes
growth-positive
Liron Wand and Jonathan Glazer join Pitango as Venture Partners | CTech
Israeli venture capital firm Pitango has announced the appointment of two new Venture Partners, Liron Wand and Dr. Jonathan Glazer. Wand, who has previously worked at Google and Facebook, will join Pitango Growth’s team. Dr. Glazer, the former Head of the Ambulatory Care Service in Tel Aviv Sourasky Medical Center’s Emergency Department, will join the Healthtech team. Pitango has raised more than $2.8 billion to date and invests via three dedicated funds: Pitango First, Pitango Growth and Pitango HealthTech.
Management ChangesInvestment
Growth-Positive
250 companies and $6.5 billion: An in-depth look at Israel's healthtech industry
Pitango HealthTech Fund has released a first-of-its-kind map of the Israeli healthcare startup industry, showcasing a diverse landscape of innovation. The fund examined Israels 1,500 healthcare companies, narrowing down to around 250 of the most active startups in Digital Health, Medical Devices, and Biopharma. These startups have raised a combined total of $6.5 billion since their inception. The report highlights a shift in business models, with healthcare startups no longer solely relying on technology, clinical data, or IP to generate value. Instead, they are reinventing business models and elevating the industry.
Investment
growth-positive
Digital Health Startup Alike Raises $5M Funding Round Led By Pitango HealthTech Fund
Israeli startup Alike has raised $5 million in a seed round led by Pitango Venture Capitals HealthTech fund. Alike aims to empower patients by translating complex medical data into accessible information and connecting them with similar populations. The company leverages AI, big data, and crowdsourcing to achieve these insights. Alike was founded by digital health and high-tech entrepreneurs, including Amnon Bar-Lev and Prof. Varda Shalev. The company plans to recruit 15 more employees by the end of the year. Pitangos HealthTech fund sees Alike as a special place that will change how people use their medical information.
InvestmentExpand
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Pitango HealthTech Internal
Recent Updates
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-06-27 11:07:00.000000
Matan Eblagon
· matane@sncentral.org · Manual · 2023-09-06 13:13:53.000000
Joel Schoppig
· joel.s@pitango.com · Manual · 2023-06-28 07:40:50.000000
Joel Schoppig
· joel.s@pitango.com · Manual · 2023-06-27 11:14:11.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 11:17:40.000000
Joel Schoppig
· joel.s@pitango.com · Manual · 2023-06-28 07:37:49.000000
Joel Schoppig
· joel.s@pitango.com · Manual · 2023-06-28 08:52:04.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 10:57:50.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 13:25:18.000000
Hamutal Duchan
· hamutal.d@pitango.com · Manual · 2025-02-09 08:37:38.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2025-09-14 13:34:11.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-09-10 08:04:55.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 10:53:38.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 10:53:57.000000
Doron Bobman
· doron.b@sncentral.org · Manual · 2025-01-12 09:06:23.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2025-09-14 13:34:32.000000
Doron Bobman
· doron.b@sncentral.org · Manual · 2025-02-09 08:35:39.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2025-07-27 11:02:33.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 11:11:03.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 10:52:54.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 10:45:18.000000
Doron Bobman
· doron.b@sncentral.org · Manual · 2025-01-12 09:26:11.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 11:17:54.000000
Hamutal Duchan
· hamutal.d@pitango.com · Manual · 2025-05-26 08:20:00.000000
Joel Schoppig
· joel.s@pitango.com · Manual · 2023-06-28 07:40:17.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2025-09-14 13:34:11.000000
Elana Steinbach
· elanas@sncentral.org · Manual · 2023-04-23 10:57:50.000000
Joel Schoppig
· joel.s@pitango.com · Manual · 2023-06-28 07:37:49.000000
Joel Schoppig
· joel.s@pitango.com · Manual · 2023-06-28 08:51:27.000000
Efrat Kotler
· efrat.k@pitango.com · Manual · 2025-09-20 14:57:49.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 55/100 |
| Missing | product stage, sector, number of employees, business model, tag line, video or image, funding rounds, markets, not claimed |
| Crunchbase | fund/pitango-venture-capital-raised-health-tech-fund--10dcd0c5 |
| Creator | Elana Steinbach |
| Creator email | elanas@sncentral.org |
| Last updater | Doron Bobman |
| Updater email | doron.b@sncentral.org |
| Last update | 2025-01-13T00:00:00.000Z |
| Created | 2023-04-23T00:00:00.000Z |